News Transactions under Novozymes’ stock buyback program Staff February 15, 2021 Please read the full announcement in the attached PDF Attachment 2021_07_Stock_Buybackprogram Iframe sync Post navigation Previous: Synairgen announces that dosing has commenced with its inhaled interferon beta product in US Government-funded NIH ACTIV-2 trial in COVID-19 outpatientsNext: Alimera Sciences to Present at the Microcap Rodeo Winter Wonderland Conference More Stories Healthcare News Robotics Medtronic announces filing of IPO registration statement for Diabetes business, MiniMed Staff December 19, 2025 News Pinealage: the app that turns strangers into meditation companions — in crowdfunding phase Staff December 19, 2025 Cancer News Pharmaceutical IMG Saxony-Anhalt: 2026 in Sight – Saxony-Anhalt Sets the Pace for Future Industries Staff December 19, 2025
